Literature DB >> 17074670

Anticancer drug discovery and pharmaceutical chemistry: a history.

Miguel F Braña1, Ana Sánchez-Migallón.   

Abstract

There are several procedures for the chemical discovery and design of new drugs from the point of view of the pharmaceutical or medicinal chemistry. They range from classical methods to the very new ones, such as molecular modeling or high throughput screening. In this review, we will consider some historical approaches based on the screening of natural products, the chances for luck, the systematic screening of new chemical entities and serendipity. Another group comprises rational design, as in the case of metabolic pathways, conformation versus configuration and, finally, a brief description on available new targets to be carried out. In each approach, the structure of some examples of clinical interest will be shown.

Mesh:

Substances:

Year:  2006        PMID: 17074670     DOI: 10.1007/s12094-006-0118-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  22 in total

Review 1.  Strategies for optimizing combinations of molecularly targeted anticancer agents.

Authors:  Janet E Dancey; Helen X Chen
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

2.  Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid.

Authors:  S FARBER; L K DIAMOND
Journal:  N Engl J Med       Date:  1948-06-03       Impact factor: 91.245

3.  The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides.

Authors:  A Gilman; F S Philips
Journal:  Science       Date:  1946-04-05       Impact factor: 47.728

4.  New antitumor agents containing the anthracene nucleus.

Authors:  T P Wunz; R T Dorr; D S Alberts; C L Tunget; J Einspahr; S Milton; W A Remers
Journal:  J Med Chem       Date:  1987-08       Impact factor: 7.446

5.  Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.

Authors:  T Ishikawa; F Sekiguchi; Y Fukase; N Sawada; H Ishitsuka
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

6.  Preliminary trial of aminoglutethimide in breast cancer.

Authors:  C T Griffiths; T C Hall; Z Saba; J J Barlow; H B Nevinny
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

7.  Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.

Authors:  J Feigon; W A Denny; W Leupin; D R Kearns
Journal:  J Med Chem       Date:  1984-04       Impact factor: 7.446

8.  Current status of research on the alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don).

Authors:  G H SVOBODA; I S JOHNSON; M GORMAN; N NEUSS
Journal:  J Pharm Sci       Date:  1962-08       Impact factor: 3.534

9.  Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.

Authors:  J Sosinski; J H Thakar; G S Germain; P Dias; F C Harwood; J F Kuttesch; P J Houghton
Journal:  Mol Pharmacol       Date:  1994-05       Impact factor: 4.436

10.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

View more
  3 in total

Review 1.  Natural products as leads to anticancer drugs.

Authors:  M Gordaliza
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

2.  Novel microwave-assisted synthesis of the immunomodulator organotellurium compound ammonium trichloro(dioxoethylene-O,O')tellurate (AS101).

Authors:  M Pilar Vázquez-Tato; Alberto Mena-Menéndez; Xesús Feás; Julio A Seijas
Journal:  Int J Mol Sci       Date:  2014-02-21       Impact factor: 5.923

3.  Synthesis, characterization and biological evaluation of dipicolylamine sulfonamide derivatized platinum complexes as potential anticancer agents.

Authors:  Nadini Thushara; Taniya Darshani; Sameera R Samarakoon; Inoka C Perera; Frank R Fronczek; W M C Sameera; Theshini Perera
Journal:  RSC Adv       Date:  2021-05-14       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.